Newsletter Subject

New Consensus Report: Myopia Should Be Classified as a Disease

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Sep 20, 2024 10:44 PM

Email Preheader Text

Daily Headlines Friday, September 20, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIG

[MEDPAGE TODAY]( Daily Headlines Friday, September 20, 2024 Today's Top Stories for {NAME} [OPHTHALMOLOGY]( [New Consensus Report: Myopia Should Be Classified as a Disease]( [WASHINGTON-WATCH]( [FTC Sues Top Pharmacy Benefit Managers Over Insulin Prices]( [SPOTLIGHT ON]( [Turning 'Cold' Tumors Into 'Hot' Tumors]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Navigating the Nuances of von Hippel-Lindau (VHL) Disease Care: A Clinical Challenge in Treatment and Management]( [MEETING COVERAGE]( [Kids With MS May Have Better Outcomes When Started on High-Efficacy Treatment Early]( [NURSING]( [Documentary Explores Racism, Gatekeeping in Nursing]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [INFECTIOUS DISEASE]( [FDA OKs First Flu Vaccine for At-Home Use]( CME SPOTLIGHT [Optimizing Treatment With Infusion-Based Therapies for HR+/HER2- and Triple-Negative Breast Cancer]( [PERSPECTIVES]( [A Georgia Woman's Death After Delayed Abortion Care Was Preventable. Who's to Blame?]( [SPOTLIGHT ON]( [Cytokine Release Syndrome and Neurotoxicity After CAR T-Cell Therapy]( [CARDIOLOGY]( [Reconsider When a Prophylactic ICD Is Needed in Nonischemic Dilated Cardiomyopathy]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Mastering Mast Cell Mysteries: A Clinical Case Challenge in Recognizing and Managing Indolent Systemic Mastocytosis]( [GENETICS]( [First Drug Approved for Niemann-Pick Disease Type C]( [PSYCHIATRY]( [U.S. Will Let More People Take Methadone at Home]( [AAD READING ROOM]( [Adherence Strategies to Help for Psoriasis (and All) Patients That Might Actually Work]( CME SPOTLIGHT [Transforming MM Management: Key Strategies for Infectious Disease Teams Using Bispecific Antibodies]( [MEETING COVERAGE]( [Tolebrutinib Slows Disability in Non-Relapsing Secondary Progressive MS]( [PUBLIC HEALTH & POLICY]( [Exposure to Air Pollution Linked to Increased Risk of Parkinson's Disease]( [ASCO READING ROOM]( [An 'Exciting' Time for Small-Cell-Lung Cancer Treatment]( CME SPOTLIGHT [Empowering Historically Underrepresented Patients: Overcoming Healthcare Disparities in Multiple Myeloma]( CME SPOTLIGHT [Precision Targeting in Acute Myeloid Leukemia: Optimizing Disease-Informed, Patient-Centered Care]( # Weekly Survey [Recommending New COVID Vaccines?]( The FDA authorized updated [mRNA]( and [non-mRNA]( COVID vaccines for the 2024-2025 respiratory virus season[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-09-20&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.